Medical countermeasures protecting people from public health emergencies.
Emergent BioSolutions develops and manufactures medical countermeasures designed to protect people from chemical, biological, radiological, and nuclear threats, as well as infectious disease outbreaks. The company works with governments and health agencies to ensure readiness for public health emergencies before they occur. On MarketScale, Emergent BioSolutions shares content on preparedness policy, manufacturing, and the science behind medical countermeasure development.
Addiction stigma blocks care; access unlocks recovery
This channel argues that public perception and accessible tools—not shame—determine whether people seek addiction treatment. It grounds that thesis in personal testimony and a concrete policy win: OTC naloxone.
Emergent BioSolutions' channel contends that stigma and fear are the primary barriers preventing millions from seeking substance use disorder treatment, and that normalizing addiction and removing access barriers can unlock recovery pathways. The content supports this through direct testimony from practitioners like Allie Hunter, who experienced firsthand how lack of knowledge and tools deepened family crisis, and through the tangible policy victory of OTC naloxone, which the channel frames as proof that barrier removal works.
Drawn from Impacting the Stigma and 2 more →
“People are more likely to follow someone who is authentic, even if they are not always perfect.”
Dr. Jen Welter, first woman to coach in the NFL
By the numbers
What the channel argues
Who and what shows up
Allie Hunter
Director, Community Health Solutions
Shared personal experience of helplessness during sister's ten overdoses; now drives work to equip others with support tools she lacked.
Dr. Jen Welter
First woman to coach in the National Football League
Articulates how authentic leadership builds trust and persistence matters in breaking through male-dominated institutions.
Questions this channel answers
What prevents people from seeking addiction treatment?
Stigma, shame, and fear of judgment keep millions from seeking help. People feel ashamed and isolated, and family members fear being judged if they discuss it.
Impacting the Stigma →How can we make addiction treatment more accessible?
Normalize the idea of addiction, reduce stigma, and ensure accessible and affordable resources are available to people who need help.
Impacting the Stigma →What does it take to move a medication to OTC status?
Teamwork, hard work, collaboration, and deliberate focus on accessibility and barrier removal enable products like naloxone to reach mainstream availability.
The Impact of Naloxone OTC →How do you lead through challenge in a male-dominated field?
Lead with authenticity and honesty, be persistent, and recognize that people follow authentic leaders even when they are not perfect.
Leading the Charge →Best place to start
Impacting the StigmaFrames the core problem, establishes why stigma blocks care, and sets up the channel's thesis on access and normalization.
The Impact of Naloxone OTCOffers concrete proof that barrier removal and collaboration deliver real public health outcomes, making the channel's argument concrete.Industry context
Social stigma remains a significant barrier to substance abuse treatment adoption, according to market analysis projections through 2035.
Latest media
Episodes
Follow the channel
Get new Emergent BioSolutions episodes in your inbox.
Subscribe to follow the conversation. We send a short note when new episodes and contributions go live.